Skip to main content
Fig. 3 | Experimental Hematology & Oncology

Fig. 3

From: COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU

Fig. 3

Thirty-day survival rates and associated risk factors, including increased D-dimer and FDP concentrations, platelet count of ≤ 150 × 109/L, SIC score of ≥ 4, DIC score of ≥ 5 and overt DIC. The 30 day survival rate was significant after patients with severe coagulopathy were selected as follows: patients with a DIC score of ≥ 5 (p = 0.022), D-dimer concentration of > 2 mg/L (p = 0.045), or confirmed overt DIC (p = 0.043). FDP, fibrin degradation products; PLT, platelet count; SIC, sepsis-induced coagulopathy; DIC, disseminated intravascular coagulation; VTE, venous thromboembolism

Back to article page